Marlow, United Kingdom

Hazel M Noble

This inventor holds 1 USPTO granted patent. Top assignee: Beecham Group Plc. Active years: 1984.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hazel M Noble. Retrieved from https://idiyas.com/inventor/hazel-m-noble-r8v7946x

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 1984

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Hazel M Noble: Innovator in Pharmaceutical Chemistry

Introduction

Hazel M Noble is a distinguished inventor based in Marlow, GB. She has made significant contributions to the field of pharmaceutical chemistry, particularly through her innovative work on clavulanic acid.

Latest Patents

Hazel M Noble holds a patent for "Pure salts of clavulanic acid, e.g. lithium clavulanate." This invention provides the compound (2R,5R,Z)-3-(2-hydroxyethylidene)-7-oxo-4-oxa-1-azabicyclo-[3,2,0]-heptane-2-carboxylic acid and its salts in purified form. The patent also details pharmaceutical compositions containing these compounds and a process for their purification by converting them in aqueous media to the lithium salt of the acid and precipitating it.

Career Highlights

Noble is associated with Beecham Group Plc, where she has been instrumental in advancing pharmaceutical research and development. Her work has had a lasting impact on the industry, particularly in the area of antibiotic development.

Collaborations

Throughout her career, Hazel has collaborated with notable colleagues, including Ian D Fleming and David Noble. These partnerships have fostered innovation and contributed to the success of her projects.

Conclusion

Hazel M Noble's contributions to pharmaceutical chemistry exemplify the vital role of inventors in advancing medical science. Her innovative work continues to influence the field and improve healthcare outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…